AI assistant
CORCEPT THERAPEUTICS INC — Director's Dealing 2011
Feb 1, 2011
30681_dirs_2011-02-01_811aa79c-5c7f-4faf-bfbb-988be546140c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2011-02-01
Reporting Person: WILSON JAMES N (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-02-01 | Common Stock | S | 10000 | $4.0935 | Disposed | 2054511 | Indirect |
| 2011-02-01 | Common Stock | S | 5000 | $4.104 | Disposed | 941774 | Indirect |
Footnotes
F1: The sale is made pursuant to terms of a 10b5-1 plan in effect at the time of sale of the shares.
F2: Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $4.08 to $4.11 per share. Full information on the numbers of shares sold at each sale price is available upon request.
F3: Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $4.08 to $4.12 per share. Full information on the numbers of shares sold at each sale price is available upon request.